OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹40 Cr | ₹31 Cr | ₹61 Cr | ₹52 Cr | ₹14 Cr |
What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?
Year | Revenue |
---|---|
Mar2024 | ₹40 Cr |
Mar2023 | ₹31 Cr |
Mar2022 | ₹61 Cr |
Mar2021 | ₹52 Cr |
Mar2020 | ₹14 Cr |
How is Revenue of OXYGENTA PHARMACEUTICAL Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹40 Cr | 27.93 | |
Mar2023 | ₹31 Cr | -48.80 | |
Mar2022 | ₹61 Cr | 16.33 | |
Mar2021 | ₹52 Cr | 279.32 | |
Mar2020 | ₹14 Cr | - |
Compare Revenue of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹221.3 Cr | -3% | -14.6% | -33.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,862.0 Cr | -0.3% | 3.2% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,458.0 Cr | 7.2% | 8.6% | 6.8% | Stock Analytics | |
CIPLA | ₹125,842.0 Cr | 3% | 0.7% | -2.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,547.0 Cr | -0.5% | NA | 0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,866.0 Cr | -1.1% | -5.3% | -6.3% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -3% |
-14.6% |
-33.5% |
SENSEX | 1% |
0.9% |
1.2% |
You may also like the below Video Courses